Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000457660 | SCV000563824 | pathogenic | Fumarase deficiency | 2017-01-12 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the FH gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Loss of function variants in FH are known to be pathogenic. A deletion of the entire gene has been reported in patients with hereditary leiomyomatosis and renal cancer, multiple cutaneous and uterine leiomyomatosis, reduced FH enzyme activity (PMID: 12761039, 21398687, 11865300), and fumarase deficiency (PMID:22069215). For these reasons, this variant has been classified as Pathogenic. |